 TEL AVIV, Israel and BETHESDA, Maryland, Sept. 21, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. CNBX, a global leader in the development of cancer related cannabinoid-based medicine, announced today the hire of Dr. David Sans FAARM, PhD, MBA in New York to expand its current pipeline of clinical development assets in Mental Health Diseases. 